Metronomia is proud to announce some significant business developments in recent months:

• Bids for two multinational studies with biotech products were won.
• Metronomia was qualified by a well-known German pharma company for statistical and statistical programming services after an intensive process with several audits and qualification activities. The first contract has been signed and the project is about to kick off during the next weeks. 
• Metronomia has been selected preferred partner for all data management and biostatistical services of a mid-sized German pharmaceutical company. A significant number of clinical studies will be jointly be started in 2018 - in Europe and the US.